Biogen (BIIB) Tops Q3 EPS by 31c; raises guidance
Tweet
Share
E-mail
Get Alerts BIIB Hot Sheet
Price: $199.71 +1.59%
Revenue Growth %: -6.5%
Financial Fact:
Basic earnings per share attributable to Biogen Idec Inc.: 218.9M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: -6.5%
Financial Fact:
Basic earnings per share attributable to Biogen Idec Inc.: 218.9M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Biogen (NASDAQ: BIIB) reported Q3 EPS of $4.08, $0.31 better than the analyst estimate of $3.77. Revenue for the quarter came in at $2.47 billion versus the consensus estimate of $2.43 billion.
GUIDANCE:
Biogen sees FY2024 EPS of $16.10-$16.60, versus the consensus of $16.19.
For earnings history and earnings-related data on Biogen (BIIB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Primoris cuts 2026 outlook on renewables cost overruns, COO exits
- ZenaTech raises Plurilock Security stake to 12% with new share purchase
- S&P Global (SPGI) Declares $0.97 Quarterly Dividend; 1% Yield
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
